We evaluated the diagnostic performance of the baseline diffusion weighted imaging (DWI) and the apparent diffusion coefficient (ADC) in the prediction of a complete pathologic response (pCR) to neoadjuvant chemotherapy (NAC) in patients with breast cancer stratified according to the tumor phenotype.
Bufi, E., Belli, P., Costantini, M., Cipriani, A., Di Matteo, M., Bonatesta, A., Franceschini, G., Terribile, D. A., Mule', A., Nardone, L., Bonomo, L., Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer, <<CLINICAL BREAST CANCER>>, 2015; (Febbraio): N/A-N/A. [doi:10.1016/j.clbc.2015.02.002] [http://hdl.handle.net/10807/67087]
Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
Bufi, Enida;Belli, Paolo;Costantini, Melania;Cipriani, Antonio;Di Matteo, Marialuisa;Bonatesta, Angelo;Franceschini, Gianluca;Terribile, Daniela Andreina;Mule', Antonino;Nardone, Luigia;Bonomo, Lorenzo
2015
Abstract
We evaluated the diagnostic performance of the baseline diffusion weighted imaging (DWI) and the apparent diffusion coefficient (ADC) in the prediction of a complete pathologic response (pCR) to neoadjuvant chemotherapy (NAC) in patients with breast cancer stratified according to the tumor phenotype.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
